SAST, DAST, fuzzing, and pentest-class test cases, run continuously by the platform and traced to every component, interface, and data flow of every release. Built on 13 years of putting medical device findings through FDA review, not on a prompt. No scoping call, no vendor calendar, no report that is stale before anyone reads it.
Each discipline catches what the others miss. ELTON runs them together across hardware, firmware, software, web, mobile, and network, on every release you cut. The twin hands the agents context no generic tool has, and TestLink™ carries the whole pipeline onto the physical device.
SAST reads source and binaries for weakness patterns. DAST probes the running services the way an attacker would. Both run per release, not per contract.
Protocol and interface fuzzing pushes malformed traffic through DICOM, HL7, MQTT, and proprietary listeners until something breaks, or demonstrably does not.
The moves a human tester would make, encoded as executable test cases: authentication bypass, session abuse, chained access across trust boundaries.
Any frontier model can reason. The harness is what turns reasoning into work: driving physical interfaces, coordinating scanner, exploit, and validator agents, carrying the twin as context, recovering when something fails. A web-app harness is not a firmware harness. Ours was built for the hard case.
Thirteen years of testing medical devices, and more than a thousand submissions where our findings, ratings and dispositions had to survive a reviewer. That experience is what the pipeline is built from. It is not a prompt, and it did not start last year.
A consultant can paste your source code into a model and prompt it to find vulnerabilities. That works, sometimes. It also runs differently every time, produces no coverage assessment and no traceability, and ends with findings handed to you by people who cannot explain them. Volume is not the same as evidence.
Every TestLink™ appliance is a pentester in a box, cabled to a real device and run from one console over out-of-band 5G. Watch the fleet: boxes connected, units online, sessions live, latency to each. One bench or a deployment grid, no lab required.
A finding is not closed by opinion. Every test case comes from the device’s own threat model, runs at the deepest tier you open, and lands as evidence: an unbroken chain from CVE to determination that reviewers can follow. Deeper access closes more findings as Not Affected, and every VEX statement gets stronger.
Raw tool output is where triage drowns. Here, every lane feeds exploitability verification before a human ever sees it, so what reaches your team is deduplicated, verified, and evidenced.
Four lanes rediscover the same weakness four different ways. The platform collapses them into one finding before anyone spends a minute on triage.
Findings pass through L1, L2, and L3 verification, so developers only ever see work that survived a real exploitation attempt.
What is exploitable today ships as a vulnerability. What is latent is tracked as a weakness and stays out of the release path.
Run the full testing stack against your next release and watch verified findings, not a PDF, arrive in the platform.